Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009368:Neoplasm Transplantation; D009942:Organometallic Compounds / Q000627:therapeutic use*; D013997:Time Factors; D014025:Titanium / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009942:Organometallic Compounds; C037461:difluorobis(1-phenyl-1,3-butanedionato)titanium (IV); C037463:dichlorobis(1-phenyl-1,3-butanedionato)titanium (IV); C037462:dibromobis(1-phenyl-1,3-butanedionato)titanium (IV); D014025:Titanium; D002945:Cisplatin